Top & Current
Thu, February 4, 2021
[ Thu, Feb 04th 2021
] - WOPRAI
Wed, January 6, 2021
[ Wed, Jan 06th 2021
] - WOPRAI
Mon, August 3, 2020
[ Mon, Aug 03rd 2020
] - WOPRAI
Thu, June 25, 2020
[ Thu, Jun 25th 2020
] - WOPRAI
Thu, June 11, 2020
[ Thu, Jun 11th 2020
] - WOPRAI
Mon, May 4, 2020
[ Mon, May 04th 2020
] - WOPRAI
Mon, April 20, 2020
[ Mon, Apr 20th 2020
] - WOPRAI
Tue, March 24, 2020
[ Tue, Mar 24th 2020
] - WOPRAI
Mon, February 10, 2020
[ Mon, Feb 10th 2020
] - WOPRAI
Mon, January 6, 2020
[ Mon, Jan 06th 2020
] - WOPRAI
Thu, January 2, 2020
[ Thu, Jan 02nd 2020
] - WOPRAI
Thu, July 11, 2019
[ Thu, Jul 11th 2019
] - WOPRAI
Mon, August 13, 2018
Fri, August 4, 2017
Mon, November 3, 2014
[ Mon, Nov 03rd 2014
] - WOPRAI
Mon, January 6, 2014
[ Mon, Jan 06th 2014
] - WOPRAI
Randall Stanicky Maintained (ABBV) at Buy with Increased Target to $135 on, Feb 4th, 2021
Randall Stanicky of RBC Capital, Maintained "AbbVie Inc." (ABBV) at Buy with Increased Target from $129 to $135 on, Feb 4th, 2021.
Randall has made no other calls on ABBV in the last 4 months.
There are 6 other peers that have a rating on ABBV. Out of the 6 peers that are also analyzing ABBV, 1 agrees with Randall's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $110 on, Friday, December 11th, 2020
These are the ratings of the 5 analyists that currently disagree with Randall
- David Risinger of "Morgan Stanley" Maintained at Buy with Decreased Target to $116 on, Thursday, January 28th, 2021
- Navin Jacob of "UBS" Maintained at Strong Buy with Increased Target to $124 on, Friday, December 11th, 2020
- Steve Scala of "TD Cowen" Maintained at Buy with Increased Target to $120 on, Thursday, December 10th, 2020
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $120 on, Monday, November 30th, 2020
- Gary Nachman of "BMO Capital" Initiated at Buy and Held Target at $123 on, Wednesday, November 18th, 2020